Ipek Yonal Hindilerden

4PUBLICATIONS
92CO-AUTHORS
HaematologyRegenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 24, 2026
A practical tool for predicting outcomes in essential thrombocythemia: Triple A risk model and beyond.

Özge Sönmez, Esiyla Oyur, İpek Yönal Hindilerden

|Jun 03, 2022
Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

Murat Özbalak, Metban Güzel Mastanzade, Özden Özlük

|Sep 15, 2021
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden

|Jun 25, 2021
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study.

Olga Meltem Akay, Murat Ozbalak, Mustafa Pehlivan

Pageof 1

Frequent Collaborators

2 joint publications

Murat Ozbalak

2 joint publications

Meliha Nalçacı

2 joint publications

Sevgi Kalayoğlu Beşışık

2 joint publications

Selami Koçak Toprak